Dr Wen on the Evaluation of Tovorafenib in Young Patients with Low-Grade Glioma
December 5th 2023Patrick Y. Wen, MD, discusses the efficacy of the pan-RAF inhibitor tovorafenib in children and young adults with low-grade glioma and highlights the importance of continual clinical research in this disease.
Read More